期刊文献+

LC-MS/MS法测定小鼠血浆及组织中伊曲康唑浓度 被引量:1

LC-MS/MS determination of itraconazole in mice plasma and its tissue
原文传递
导出
摘要 目的:建立LC-MS/MS法测定小鼠血浆及组织中伊曲康唑的浓度。方法:以尼莫地平为内标,采用乙腈-水-甲酸(80∶20∶0.2)为流动相,以Waters XTerraMS-C18色谱柱(2.1mm×150mm,3.5μm)为分析柱,流速为0.2mL·min-1,采用电喷雾电离(ESI),以多反应离子监测(MRM)方式进行正离子检测。用于定量分析的离子反应分别为m/z705.3→392.1(伊曲康唑)和m/z419.3→343.3(内标,尼莫地平)。结果:测定血浆及组织中伊曲康唑的线性范围为10.0~1600.0μg·L-1,定量下限为10.0μg·L-1。日内、日间精密度(RSD)小于9.7%,方法回收率为99.0%~109.8%。结论:本方法灵敏度高、专属性强、操作简便,适用于伊曲康唑脂质体在小鼠体内组织分布研究。 Objective:To establish an LC-MS/MS method for the determination of itraconazole in plasma and tissue of mice.Methods:A Waters XTerraMS-C18 column(2.1 mm×150 mm,3.5 μm)was adopted with the mobile phase consisted of acetonitrile-water-formic acid(80∶20∶0.2,v/v/v)at a flow rate of 0.20 mL·min-1.Nimodipine was used as the internal standard.Waters Micromass Quattro API tandem mass spectrometer equipped with electrospray ionization source(ESI)was used as detector operated in the positive ion mode.Multiple reaction monitoring(MRM)with the precursor to product ion combinations of m/z 705.3→392.1 and m/z 419.3→343.3 were performed to quantify itraconazole and the internal standard(nimodipine),respectively.Results:The linear calibration curves were obtained in the concentration range of 10.0-1600.0 μg · L-1.The lowest limit of quantification was 10.0 μg·L-1 .The inter-and intra-day precision(RSD)was less than 9.7%.The method recoveries were within 99.0%~109.8%.Conclusion: The method was proved to be sensitive,rapid,convenient and suitable for tissue distribution of itraconazole liposomes in mice.
出处 《药物分析杂志》 CAS CSCD 北大核心 2010年第3期389-392,共4页 Chinese Journal of Pharmaceutical Analysis
基金 黑龙江省重点科技项目(GB06C307)
关键词 伊曲康唑 LC-MS/MS法 脂质体 组织分布 itraconazole liquid chromatography-tandem mass spectrometry liposome tissue distribution
  • 相关文献

参考文献12

  • 1Karel DB,Jef VGPharmacology of itraconazoleDrugs,2001,61(1):27.
  • 2蔡永宁,梁德荣,朱焕玲,沈奇,刘挺,王霞,黄杰.伊曲康唑注射液治疗深部真菌感染[J].中国新药杂志,2004,13(2):161-163. 被引量:22
  • 3孙忠实,朱珠.伊曲康唑注射液述评[J].中国药学杂志,2003,38(8):630-632. 被引量:8
  • 4董迪,刘红梅,宋笑丹,吴琳华.反相高效液相色谱法测定伊曲康唑脂质体药物含量及包封率[J].药物分析杂志,2007,27(9):1453-1455. 被引量:3
  • 5Vijaya DB,Kishore KH,Vidya PP,et al.Development and validation of a highly sensitive and robust LC MS/MS with electrospray ionization method for simultaneous quantitation of itraconazole and hydroxyitraconazole in human plasma:Application to a bioequivalence study.J Chromatogr B,2008,868:70.
  • 6Tomoya O,Kazuki N,Susumu N,et al.Effect of itraconazole on the pharmacokinetics of imidafenacin in healthy subjects.J Clin Pharmacol.2008,48 ( 3 ) :330.
  • 7Tell LA,Craigmill AL,Clemons KV,et al.Studies on itraconazole delivery and pharmacokinetics in mallard ducks.J Vet Pharmacol Ther,2005,28:267.
  • 8Jee HS,Ka YC,Yu CK,et al.Dose-dependent pharmacokinetics of itraconazole after iIntravenous or oral administration to rats:intestinal first-pass effect.Antimicrob Agents Chemother,2004,48(5):1756.
  • 9Jason TM,Krik AO,Praposri S,et al.Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model.Pharm Res,2006,23(5):901.
  • 10陈丽娟.HPLC测定人血浆中伊曲康唑的浓度[J].华西药学杂志,2006,21(3):293-295. 被引量:10

二级参考文献35

  • 1虞瑞尧.伊曲康唑的药理及其临床应用[J].新药与临床,1989,8(2):88-91. 被引量:2
  • 2张明宇,尹鸿萍,王旻,周建平.紫外分光光度法测定伊曲康唑注射液的含量[J].江苏药学与临床研究,2005,13(4):13-14. 被引量:5
  • 3杜斌,张海涛,陈德昌,刘大为,侯百东,熊雯,刘彤华,陈杰.3447例尸检病例的深部真菌感染分析[J].中华医学杂志,1996,76(5):352-354. 被引量:119
  • 4Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000[J ]. N Engl J Med, 2003 ; 348 : 1546.
  • 5Kontoyiannis DP, Lewis RE. Antifungal drug resistance of pathogenic fungi[J ]. Lancet, 2002,359:1135.
  • 6Potter M. European experience with oral solution and intravenous itraconazole[ J ]. Oncology ,2001,15( 11 Suppl 9) :27.
  • 7Boogaerts M, Winston DJ, Bow EJ, et al. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy[J ]. Ann Intern Med,2001 ; 135:412.
  • 8Physicians' Desk Reference (PDR) (54th ed)[M]. Medical Economics Company-Thomson Healtheare, 2000:1460-- 1462.
  • 9Parfitt K. Martindale The complete drug reference [ M].32nd ed. Pharmaceutical press, 1999;381.
  • 10De Beule K, Van Gestel J. Pharmacology of itraconazole [ J ].Drugs ,2001,61(Suppl 1) :27.

共引文献42

同被引文献12

  • 1苏文娟,黄熙,秦峰,江莉,任平.大鼠灌胃厚朴及厚朴三物汤后和厚朴酚的药动学比较[J].中药材,2008,31(2):255-258. 被引量:13
  • 2丁郁文.HPLC法测定厚朴酚含量的探讨[J].陕西中医,2008,29(6):733-734. 被引量:3
  • 3王贺玲,白菡,王学清,李岩.厚朴对实验大鼠的胃动力影响[J].实用药物与临床,2007,10(2):65-66. 被引量:44
  • 4LI Wei-min(李卫民).Study on compatibility screening,pharmacodynamic action and pharmacokinetics of traditional Chinese medicine compound that was studied out by ourselves(厚朴咳喘方的药代动力学及药效学研究):Thesis(学位论文).Guangzhou(广州):Guangzhou University of Traditional Chinese Medicine(广州中医药大学),2005.
  • 5XU Shu-yun(徐淑云).Practical Pharmacology(实用药理学).Beijing(北京):Peoples Medical Publishing House(人民卫生出版社),Appendix(附录):2005.1861.
  • 6Wu XN,Chen XG,Hu ZD.High-performance liquid chromatographic method for Simultaneous determination of honokiol and magnolol in rat plasma.J Talanta,2003,59:118.
  • 7Chen CL,Chang PL,Lee SS,et al.Analysis of magnolol and honokiol in biological fluids by capillary zone electrophoresis.J Chromatogr A,2007,1142:243.
  • 8Lee YC,Huang CY,Wen KC,et al.Determination of liquiritin,glycyrrhizin,hesperidin,cinnamic acid,cinnamaldehyde,honokiol and magnold in the traditional Chinese medicine preparation Wuu-ji-san by high-performance liquid chromatography.J Chromatogr A,1995,692:137.
  • 9季宏建,周小华,邹建军,都述虎,何振伟.LC-MS/MS法测定人血浆中氯吡格雷的浓度及其药动学研究[J].中国药房,2009,20(8):584-586. 被引量:9
  • 10艾秀娟,姚惠珍,杨凤仪.HPLC法测定厚朴叶中厚朴酚与和厚朴酚[J].江西化工,2009,25(1):74-75. 被引量:5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部